Assessment of Menopausal Symptoms Using Menopausal Rating Scale and Their Association with Serum Vitamin D Levels

Abstract Menopause usually occurs around the age of 50, and when women go through menopause they generally experience unpleasant symptoms. Vitamin D is a type of steroid hormone that is required for bone health and the proper balance of calcium and phosphorus in the body. This study aimed to investigate the relationship between serum vitamin D levels and menopausal symptoms in women going through menopause using the Menopausal Rating Scale (MRS). The present study was a hospital-based observational cross-sectional study conducted on 200 participants. This study was carried out between 2024 and 2025 on all women between the ages of 40 and 65 who attended the OPD, Department of Obstetrics and Gynecology at B.R.D. Medical College, Gorakhpur. The average age of the research participants was 50.2 ± 6.8 years. Results showed that most of the patients (42%) had vitamin D deficiency (<12 ng/mL). Menopause Rating Scale (MRS) ratings scores were significantly higher in all domains (somatic, psychological, and urogenital) for women with vitamin D deficiency. The ROC analysis revealed that vitamin D predicted severe symptoms (MRS≥26) with an AUC=0.82 (p<0.001) and a cut-off ≤14.3 ng/mL. Patients with deficient vitamin D showed a higher prevalence of menopausal symptoms than those with sufficient levels, which included hot flashes (92.9% vs. 50.0%), sleep disturbances (81.0% vs. 40.9%), joint pain (85.7% vs. 45.5%), and vaginal dryness (75.0% vs. 34.1%). Vitamin D deficiency was also linked to other health problems. Vitamin D deficiency was more common in individuals that were vegetarians, experienced < 30 minutes of sun exposure each day, overweight or obese, and consumed fewer supplements and especially during the monsoon or winter seasons. These results represent the necessity of focused interventions, including dietary changes, vitamin D supplements, and lifestyle modifications, for maintaining ideal vitamin D levels and possibly minimizing the severity of menopausal symptoms.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-30
DOI
https://doi.org/10.5281/zenodo.18218981
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of Menopausal Symptoms Using Menopausal Rating Scale and Their Association with Serum Vitamin D Levels

International Journal of Medical Science and Advanced Clinical Research (IJMACR)
Zenodo (CERN European Organization for Nuclear Research)
Menopause: Health Impacts and Treatments
article

Assessment of Menopausal Symptoms Using Menopausal Rating Scale and Their Association with Serum Vitamin D Levels

International Journal of Medical Science and Advanced Clinical Research (IJMACR)
article en

Abstract

Abstract Menopause usually occurs around the age of 50, and when women go through menopause they generally experience unpleasant symptoms. Vitamin D is a type of steroid hormone that is required for bone health and the proper balance of calcium and phosphorus in the body. This study aimed to investigate the relationship between serum vitamin D levels and menopausal symptoms in women going through menopause using the Menopausal Rating Scale (MRS). The present study was a hospital-based observational cross-sectional study conducted on 200 participants. This study was carried out between 2024 and 2025 on all women between the ages of 40 and 65 who attended the OPD, Department of Obstetrics and Gynecology at B.R.D. Medical College, Gorakhpur. The average age of the research participants was 50.2 ± 6.8 years. Results showed that most of the patients (42%) had vitamin D deficiency (<12 ng/mL). Menopause Rating Scale (MRS) ratings scores were significantly higher in all domains (somatic, psychological, and urogenital) for women with vitamin D deficiency. The ROC analysis revealed that vitamin D predicted severe symptoms (MRS≥26) with an AUC=0.82 (p<0.001) and a cut-off ≤14.3 ng/mL. Patients with deficient vitamin D showed a higher prevalence of menopausal symptoms than those with sufficient levels, which included hot flashes (92.9% vs. 50.0%), sleep disturbances (81.0% vs. 40.9%), joint pain (85.7% vs. 45.5%), and vaginal dryness (75.0% vs. 34.1%). Vitamin D deficiency was also linked to other health problems. Vitamin D deficiency was more common in individuals that were vegetarians, experienced < 30 minutes of sun exposure each day, overweight or obese, and consumed fewer supplements and especially during the monsoon or winter seasons. These results represent the necessity of focused interventions, including dietary changes, vitamin D supplements, and lifestyle modifications, for maintaining ideal vitamin D levels and possibly minimizing the severity of menopausal symptoms.

Zenodo (CERN European Organization for Nuclear Research)
Advanced Pharma (US)
Good health and well-being
Openalex Percentile: Top 27%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.